Status:
COMPLETED
An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
7+ years
Brief Summary
This observational study is conducted in Africa. The aim of this observational study is to evaluate the efficacy and the incidence of serious adverse drug reactions while using insulin Levemir® under ...
Eligibility Criteria
Inclusion
- Any subject with Type 1 or Type 2 diabetes mellitus is eligible for the study, including newly-diagnosed subjects who have never received insulin or an insulin analogue before. The selection of the subjects will be at the discretion of the individual physician
Exclusion
- Subjects who are unlikely to comply with protocol, e.g., uncooperative attitude, inability to return for the final visit
- Currently being treated with insulin detemir
- Previously enrolled in this study
- Hypersensitivity to insulin detemir or to any of the excipients
- Pregnancy, breast-feeding, the intention to become pregnant or judged not to be using adequate contraceptive measures.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
798 Patients enrolled
Trial Details
Trial ID
NCT00738153
Start Date
June 1 2008
End Date
May 1 2009
Last Update
August 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Casablanca, Morocco, 20000